G.J Vergote

996 total citations
11 papers, 799 citations indexed

About

G.J Vergote is a scholar working on Analytical Chemistry, Pharmaceutical Science and Public Health, Environmental and Occupational Health. According to data from OpenAlex, G.J Vergote has authored 11 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Analytical Chemistry, 4 papers in Pharmaceutical Science and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in G.J Vergote's work include Drug Solubulity and Delivery Systems (4 papers), Analytical Chemistry and Chromatography (3 papers) and Spectroscopy Techniques in Biomedical and Chemical Research (3 papers). G.J Vergote is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Analytical Chemistry and Chromatography (3 papers) and Spectroscopy Techniques in Biomedical and Chemical Research (3 papers). G.J Vergote collaborates with scholars based in Belgium, Tanzania and Rwanda. G.J Vergote's co-authors include Jean Paul Remon, Francis Verpoort, Chris Vervaet, Annelies Vercauteren, Willy Baeyens, G. Van der Weken, Tineke Vankeirsbilck, T.R.M. De Beer, Willy R. G. Baeyens and Serge Hoste and has published in prestigious journals such as International Journal of Pharmaceutics, TrAC Trends in Analytical Chemistry and European Journal of Pharmaceutical Sciences.

In The Last Decade

G.J Vergote

11 papers receiving 745 citations

Peers

Countries citing papers authored by G.J Vergote

Since Specialization

Citations

This map shows the geographic impact of G.J Vergote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.J Vergote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.J Vergote more than expected).

Fields of papers citing papers by G.J Vergote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.J Vergote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.J Vergote. The network helps show where G.J Vergote may publish in the future.

Co-authorship network of co-authors of G.J Vergote

This figure shows the co-authorship network connecting the top 25 collaborators of G.J Vergote. A scholar is included among the top collaborators of G.J Vergote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.J Vergote. G.J Vergote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Development and validation of a direct, non-destructive quantitative method for medroxyprogesterone acetate in a pharmaceutical suspension using FT-Raman spectroscopy 2004 ·European Journal of Pharmaceutical Sciences ·T.R.M. De Beer, G.J Vergote, Willy R. G. Baeyens, Jean Paul Remon, Chris Vervaet, Francis Verpoort	37
2	The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution 2004 ·Journal of Clinical Pharmacy and Therapeutics ·Pierre Claver Kayumba, (unknown), Danstan H. Shewiyo, (unknown), G. Masuki, (unknown), G.J Vergote, (unknown), J.P. Remon, Chris Vervaet	40
3	In-line monitoring of a pharmaceutical blending process using FT-Raman spectroscopy 2004 ·European Journal of Pharmaceutical Sciences ·G.J Vergote, T.R.M. De Beer, Chris Vervaet, Jean Paul Remon, Willy R. G. Baeyens, (unknown), Francis Verpoort	85
4	Drug formulations intended for the global market should be tested for stability under tropical climatic conditions 2003 ·European Journal of Clinical Pharmacology ·Peter Risha, Chris Vervaet, G.J Vergote, Lucas Van Bortel, Jean Paul Remon	19
5	Wax beads as cushioning agents during the compression of coated diltiazem pellets 2002 ·European Journal of Pharmaceutical Sciences ·G.J Vergote, Filip Kiekens, Chris Vervaet, Jean Paul Remon	52
6	In vitro evaluation of the quality of essential drugs on the Tanzanian market 2002 ·Tropical Medicine & International Health ·Peter Risha, Danstan H. Shewiyo, (unknown), (unknown), G.J Vergote, Chris Vervaet, Jean Paul Remon	42
7	In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen 2002 ·International Journal of Pharmaceutics ·G.J Vergote, Chris Vervaet, Isabel Van Driessche, Serge Hoste, Stefaan C. De Smedt, J. Demeester, (unknown), Shaun Ruddy, Jean Paul Remon	34
8	Near-infrared FT-Raman spectroscopy as a rapid analytical tool for the determination of diltiazem hydrochloride in tablets 2002 ·European Journal of Pharmaceutical Sciences ·G.J Vergote, Chris Vervaet, Jean Paul Remon, (unknown), Francis Verpoort	49
9	Applications of Raman spectroscopy in pharmaceutical analysis 2002 ·TrAC Trends in Analytical Chemistry ·Tineke Vankeirsbilck, Annelies Vercauteren, Willy Baeyens, G. Van der Weken, Francis Verpoort, G.J Vergote, Jean Paul Remon	329
10	An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen 2001 ·International Journal of Pharmaceutics ·G.J Vergote, Chris Vervaet, Isabel Van Driessche, Serge Hoste, Stefaan C. De Smedt, J. Demeester, (unknown), Shaun Ruddy, Jean Paul Remon	105
11	Forensic determination of pregnancy hormones in human bloodstains 1991 ·Journal of the Forensic Science Society ·G.J Vergote, (unknown), (unknown), (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact